Diabetic retinopathy, a consequence of diabetes, involves damage to the retina's blood vessels, essential for vision. Initially, non-proliferative diabetic retinopathy (NPDR) causes vessel leakage and deposits, leading to swelling and vision issues. Progression to proliferative diabetic retinopathy (PDR) sees fragile vessels growing on the retina's surface, potentially causing severe vision loss or blindness if untreated.
Regular eye exams are crucial for early detection. Management focuses on controlling blood sugar, blood pressure, and cholesterol to slow progression. Advanced cases may require laser surgery or injections to reduce swelling and prevent vision loss. Early intervention significantly enhances outcomes, underscoring the importance of diabetes management and routine eye care in averting complications.
Objectives: The primary goals of vitreoretinal surgery for tractional retinal detachment in diabetic retinopathy include: 1. Minimizing intra and postoperative hemorrhages. 2. Ensuring optical media…
Background: Most deep learning systems for Diabetic Retinopathy (DR) screening rely on architectures such as ResNet and EfficientNet, with recent attention shifting towards transformer-based models.…
Introduction: Big Data and AI are transforming ophthalmology, particularly in the early detection of Diabetic Retinopathy (DR). Leveraging vast datasets and machine learning, these technologies…
Background: Diabetic retinopathy is a major cause of visual impairment in patients with diabetes mellitus, with diabetic macular edema being the principal cause of vision loss. Optical Coherence…
Purpose: To assess the diagnostic usefulness of retinal nonperfusion to classify eyes based on diabetic retinopathy (DR) severity on OCT angiography (OCTA) and determine whether wider field of view…
Purpose: Demographic representation in Diabetic Retinopathy Clinical Research (DRCR) studies is understudied and impacts the generalizability of results. This research aims to determine if the DRCR…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Diabetic Retinopathy work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Diabetic Retinopathy research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Diabetic Retinopathy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Diabetic Retinopathy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Diabetic Retinopathy are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Diabetic Retinopathy track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
